(Q74455097)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547678%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

A phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547678%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

W J Berg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547678%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

L H Schwartz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547678%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Amsterdam

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547678%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Mazumdar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547678%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

V Vlamis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547678%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

T M Law

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547678%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

D M Nanus

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547678%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R J Motzer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547678%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547678%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547678%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547678%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547678%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

353-355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547678%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1005902022076

10 November 2019

exact match

0 references

1 reference

12 December 2020

Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro

1 reference

12 December 2020

A phase II trial of interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma

1 reference

12 December 2020

Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid

1 reference

12 December 2020

Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

Phase III randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1005902022076

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547678%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 November 2019

0 references

1 reference